Directory
>
Sadik Kassim
Sadik Kassim
Gene Therapy Program (Postdoctoral Research Fellow) | RA Capital Management
Massachusetts, Boston, United States
Sadik Kassim
Summary
Sadik Kassim is a seasoned executive in the biotechnology sector, currently serving as the Chief Technology Officer for Genomic Medicines at Danaher Corporation. With a robust background in immunology and cell therapy, he has been instrumental in advancing the development of innovative therapeutic strategies, particularly in cancer treatment. His leadership experience spans multiple high-profile organizations, including Mustang Bio and Novartis, where he has successfully directed teams in process development and analytical strategies. Sadik's academic credentials include a PhD in Microbiology and Immunology from Louisiana State University, underpinning his expertise in viral immunology. He is multilingual, fluent in both French and Arabic, which enhances his ability to collaborate in diverse environments. Sadik is known for his strategic foresight in R&D and his passion for mentoring the next generation of scientists. His contributions have significantly impacted the field of gene therapy and immunotherapy, making him a prominent figure in biotechnology innovation.
Sadik Kassim
Work Experience
Advisor at
RA Capital Management
December 2021 - Present
Sadik Kassim
Education
Louisiana State University, Doctor of Philosophy (PhD), Microbiology and Immunology
January 2002 - January 2007
Tulane University, Bachelor of Science (BS), Cell/Cellular and Molecular Biology
January 1998 - January 2002
Frequently Asked Questions about Sadik Kassim
What is Sadik Kassim email address?
Sadik Kassim's primary email address is ************@danaher.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sadik Kassim work for?
Sadik Kassim is a Gene Therapy Program (Postdoctoral Research Fellow) at RA Capital Management.
Where Sadik Kassim graduated from?
Sadik Kassim holds a degree in I completed a PhD in viral immunology. Specifically, I studied and published on the innate immune response to herpes simplex virus type 1 and influenza virus. from Louisiana State University.
How can I directly contact Sadik Kassim?
To contact Sadik Kassim directly, you can use the email address ************@danaher.com. Complete contact information is available upon registration with Muraena.
Who is Sadik Kassim?
Sadik Kassim is a seasoned executive in the biotechnology sector, currently serving as the Chief Technology Officer for Genomic Medicines at Danaher Corporation. With a robust background in immunology and cell therapy, he has been instrumental in advancing the development of innovative therapeutic strategies, particularly in cancer treatment. His leadership experience spans multiple high-profile organizations, including Mustang Bio and Novartis, where he has successfully directed teams in process development and analytical strategies. Sadik's academic credentials include a PhD in Microbiology and Immunology from Louisiana State University, underpinning his expertise in viral immunology. He is multilingual, fluent in both French and Arabic, which enhances his ability to collaborate in diverse environments. Sadik is known for his strategic foresight in R&D and his passion for mentoring the next generation of scientists. His contributions have significantly impacted the field of gene therapy and immunotherapy, making him a prominent figure in biotechnology innovation.
Sadik`s contact details
************@danaher.com
************@novartis.com
Colleagues
Principal Scientist
ORISE Summer Research Fellow
Conservator Assistant
Operations Analyst - Commodities